NDT vs Levothyroxine: A Comprehensive Comparison for Thyroid Patients
A board-certified endocrinologist compares Natural Desiccated Thyroid (NDT) and synthetic levothyroxine — mechanisms, evidence, T4-to-T3 conversion, and who benefits from each.
For the more than 20 million Americans living with hypothyroidism, the choice of thyroid hormone replacement therapy is one of the most consequential medical decisions they will make. For decades, synthetic levothyroxine (T4) has been the default first-line treatment. Yet a growing number of patients — and their physicians — are asking a fundamental question: is synthetic T4 alone truly the best option, or does Natural Desiccated Thyroid (NDT) offer meaningful advantages?
As an endocrinologist who has spent years working with thyroid patients — many of whom continued to feel unwell on levothyroxine alone — I want to give you a clear, evidence-based comparison so you can have an informed conversation with your physician.
What Is Levothyroxine?
Levothyroxine is a synthetic form of thyroxine (T4), the storage form of thyroid hormone. It is sold under brand names such as Synthroid, Levoxyl, Tirosint, and Unithroid. Once ingested, the body is expected to convert T4 into the biologically active hormone T3 (triiodothyronine) as needed.
Pros of levothyroxine:
- Highly standardized and consistent dosing
- Long half-life allows once-daily administration
- Broadly available and inexpensive
- Extensive long-term safety data
Limitations:
- Provides only T4 — no T3, T2, or T1
- Assumes efficient peripheral T4-to-T3 conversion, which is impaired in many patients
- A significant subset of patients (estimates range from 10–20%) remain symptomatic despite normal TSH values on levothyroxine
What Is Natural Desiccated Thyroid (NDT)?
NDT is derived from porcine thyroid glands and contains the full spectrum of thyroid hormones the human thyroid produces: T4, T3, T2, T1, and calcitonin. Brand names include Armour Thyroid, NP Thyroid, and Nature-Throid (when available). NDT has been used clinically since the late 1800s — decades before synthetic T4 was developed.
Pros of NDT:
- Provides both T4 and T3, bypassing the conversion problem
- Contains T2, which emerging research suggests plays a role in metabolic regulation
- Many patients report improved energy, cognition, mood, and body composition compared with levothyroxine alone
- Standardized by USP monograph for consistent hormone content
Limitations:
- Shorter T3 half-life means some patients benefit from split dosing
- Not appropriate for every patient (e.g., certain cardiac conditions, pregnancy protocols)
- Requires a physician experienced in NDT titration and monitoring
The T4-to-T3 Conversion Problem
This is the heart of the debate. Levothyroxine therapy assumes the body will reliably convert T4 into T3. In reality, that conversion depends on the deiodinase enzymes (DIO1, DIO2), which are influenced by:
- Genetic polymorphisms (the DIO2 rs225014 variant is common and impairs conversion)
- Selenium, zinc, and iron status
- Chronic inflammation and cortisol dysregulation
- Insulin resistance and obesity
- Certain medications
When conversion is impaired, a patient can have a "perfect" TSH on levothyroxine while their tissues remain functionally hypothyroid. This is why lab values and how a patient *feels* can diverge so dramatically.
What Does the Research Say?
Several randomized trials and patient-preference studies have compared combination therapy (T4+T3 or NDT) with levothyroxine monotherapy:
- Hoang et al. (2013, *JCEM*) — patients randomized to NDT vs. levothyroxine showed no difference in cognitive scores, but 49% of patients preferred NDT (vs. 19% preferring levothyroxine) and lost modest weight on NDT.
- A 2018 meta-analysis in *Frontiers in Endocrinology* found that patients on combination therapy consistently reported improved mood and quality-of-life measures.
- The 2021 joint ATA/BTA/ETA consensus statement acknowledged that a subset of patients do not thrive on levothyroxine alone and that trials of combination therapy are reasonable in these patients.
The scientific tide is shifting: monotherapy is no longer considered universally optimal.
Who Might Benefit From NDT?
NDT deserves serious consideration when a patient:
- Has normal TSH and free T4 on levothyroxine but persistent hypothyroid symptoms
- Has documented low free T3 or a low free T3 / free T4 ratio
- Carries a known DIO2 polymorphism
- Has struggled with weight, brain fog, cold intolerance, or fatigue despite "optimal" labs
- Prefers a physiologic, multi-hormone approach after informed discussion
Who Should Stay on Levothyroxine?
Levothyroxine remains an excellent choice for many patients — particularly those who feel well on it, those with certain cardiac arrhythmias, patients in specific pregnancy protocols, and patients on suppressive therapy after thyroid cancer, where precise TSH control is critical.
Monitoring Matters
Whichever therapy is chosen, thoughtful monitoring is essential. In my practice, a complete panel typically includes:
- TSH
- Free T4
- Free T3
- Reverse T3
- Thyroid antibodies (TPO, TgAb)
- Ferritin, vitamin D, B12, and selenium
Treating the labs *and* the patient — not just the TSH — is the standard I hold my practice to.
The Bottom Line
There is no single "best" thyroid medication for every patient. Levothyroxine works well for many. NDT, when properly prescribed and monitored, can be life-changing for the patients whose symptoms persist on T4 alone. The right answer is the one that restores your energy, cognition, and quality of life — supported by appropriate labs and an experienced physician.
If you have been told your labs are "normal" but you still don't feel like yourself, you deserve a deeper conversation.
---
*Dr. Anna Frisch, MD, PhD is Board Certified in Endocrinology and a recognized leader in the use of Natural Desiccated Thyroid. To schedule a consultation, visit our booking page or call 833-4-THYROID.*